InvestorsHub Logo
Followers 314
Posts 24877
Boards Moderated 9
Alias Born 10/26/2008

Re: None

Thursday, 09/09/2021 8:53:03 AM

Thursday, September 09, 2021 8:53:03 AM

Post# of 1580
09/09/2021 PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
https://finance.yahoo.com/news/pds-biotech-completes-enrollment-lead-123000620.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PDSB News